Cubist Systematic Strategies’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-395
| Closed | -$8.35K | – | 2761 |
|
|
2023
Q2 | $8.35K | Buy |
+395
| New | +$8.35K | ﹤0.01% | 2080 |
|
|
2022
Q3 | – | Sell |
-800
| Closed | -$151K | – | 4017 |
|
|
2022
Q2 | $151K | Sell |
800
-822
| -51% | -$155K | ﹤0.01% | 3282 |
|
|
2022
Q1 | $404K | Buy |
1,622
+1,342
| +479% | +$334K | ﹤0.01% | 2643 |
|
|
2021
Q4 | $44K | Buy |
+280
| New | +$44K | ﹤0.01% | 3321 |
|
|
2020
Q2 | – | Sell |
-582
| Closed | -$119K | – | 2561 |
|
|
2020
Q1 | $119K | Buy |
+582
| New | +$119K | ﹤0.01% | 1865 |
|
|
2019
Q3 | – | Sell |
-563
| Closed | -$179K | – | 2554 |
|
|
2019
Q2 | $179K | Buy |
+563
| New | +$179K | ﹤0.01% | 2090 |
|
|
2015
Q2 | – | Sell |
-46
| Closed | -$389K | – | 2088 |
|
|
2015
Q1 | $389K | Buy |
46
+41
| +820% | +$347K | 0.02% | 1095 |
|
|
2014
Q4 | $40K | Buy |
+5
| New | +$40K | ﹤0.01% | 1789 |
|